Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
Rhea-AI Summary
Illumina (NASDAQ: ILMN) announced significant changes to its Board of Directors. Dr. Scott Gottlieb, who has served on the Board since 2020, has been elected as non-executive Chair. Additionally, Keith Meister, founder and Chief Investment Officer of Corvex Management, will join the Board on March 28, 2025.
Stephen MacMillan, who joined the Board in June 2023, will retire ahead of the upcoming annual shareholder meeting. Dr. Gottlieb expressed commitment to advancing the company's mission and driving profitable growth, while Meister voiced confidence in Illumina's strategy to expand its role in genomics and deliver shareholder value.
Positive
- Appointment of experienced healthcare leader Dr. Scott Gottlieb as Board Chair
- Addition of Keith Meister brings valuable investor perspective and focus on shareholder value creation
- Board restructuring signals renewed focus on profitable growth and value creation
Negative
- Relatively short tenure of departing board member MacMillan (less than 2 years) may indicate board instability
News Market Reaction – ILMN
On the day this news was published, ILMN declined 0.56%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Stephen MacMillan to retire from the Board
"I'm honored to accept this role at Illumina, a company at the forefront of our rapidly evolving industry, whose groundbreaking innovations continue to transform patient opportunities and shape the field of genomics," Dr. Gottlieb said. "I extend our gratitude to Steve for his dedication and commitment to Illumina, and I look forward to continuing to collaborate with the board and management team to advance the company's mission and to drive profitable growth. We also welcome to the board Keith Meister, who brings experience as an investor in the field of genomics along with a strong record of supporting value creation for shareholders."
Mr. MacMillan commented, "I am pleased with what Illumina has accomplished in advancing genomics and fostering groundbreaking innovations that have shaped our field, and I am grateful to the board for entrusting me with the opportunity to contribute to this remarkable company. I leave with great confidence in the board and the management team. Their collective vision, leadership, and deep commitment to scientific progress give me every reason to believe they'll continue—and indeed amplify—the transformative work we have set in motion."
"I look forward to working with Illumina's Board and strong management team," Mr. Meister said. "Illumina has the right strategy to drive the expansion of its role in helping to shape the field of genomics and expand the application of these technologies for patient care, and I'm confident in Illumina's ability to accelerate revenue growth and deliver value for shareholders."
About Scott Gottlieb, MD
Scott Gottlieb was appointed to Illumina's Board in February 2020. Dr. Gottlieb is a physician and served as the 23rd Commissioner of the
About Keith Meister
Keith Meister is Managing Partner and Chief Investment Officer of Corvex Management LP, which he founded in December 2010. Mr. Meister currently serves on the boards of directors for MGM Resorts, GeneDx and Vestis. He is Chairman of the board of directors of the Harlem Children's Zone and a member of the board of trustees for the American Museum of Natural History.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit illumina.com and connect with us on X, Facebook, LinkedIn, Instagram, TikTok, and YouTube.
Contacts
Investors:
Salli Schwartz
858-291-6421
IR@illumina.com
Media:
Samantha Beal
PR@illumina.com
View original content:https://www.prnewswire.com/news-releases/illumina-board-of-directors-elects-dr-scott-gottlieb-chair-keith-meister-to-join-board-of-directors-302410365.html
SOURCE Illumina, Inc.
FAQ
Who is the new Board Chair of Illumina (ILMN) as of March 2025?
When will Keith Meister join Illumina's (ILMN) Board of Directors?
Why is Stephen MacMillan leaving Illumina's (ILMN) Board?
What experience does Keith Meister bring to Illumina's (ILMN) Board?
